Condensed Statements of Operations (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Revenues:
Total Revenues:	$ 0	$ 0
Expenses:
Research and development expenses	313,017	25,325
General and administrative	609,657	161,605
Total Expenses:	922,674	186,930
Loss from operations	(922,674)	(186,930)
Interest expense		(9,558)
Net loss	$ (922,674)	$ (196,488)
Basic and diluted net loss per share		$ (0.01)
Weighted average common stock shares outstanding	211,419,937	18,888,971